跳至主要内容
临床试验/TCTR20200608004
TCTR20200608004已完成3 期

eardngam, alternLeardngam, alternative primary dysmenorrhea treatments besides NSAIDs: a randomized clinical trial ative dysmenorrhea treatments besides NSAIDs: a randomized clinical trial

Department of Thai Traditional and Alternative Medicine0 个研究点目标入组 240 人开始时间: 2020年6月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
240

研究概览

简要总结

This study concludes that the effectiveness of Leardngam for menstrual pain alleviation was comparable to that of mefenamic acid. It caused less gastrointestinal distress than mefenamic acid and had no effect on the menstrual cycle. Women with primary dysmenorrhea may use it as an alternative or a supplement.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 24 Years(—)
性别
Female

入选标准

  • [1]Dysmenorrhea (Numeric rating scale >3)
  • [2]frequency of dysmenorrhea >80% of cycle
  • [3]Regular menstruation
  • [4]No underlying illness
  • [5]No other gynecologic disorders
  • [6]No concurrent of drug; steroid, NSAIDs, anti-platelet, anti-hypertension, magnesium hydroxide, cyclosporin
  • [7]Normal level of laboratory chemistry values
  • [8] No history of drug/herb allery
  • [9] understanding thai language
  • [10] Normal mental status
  • [11] not pregnant status

排除标准

  • Medical complication during the trial
  • Drug allery during the trial
  • Abnormal laboratory chemistry values
  • Abnormal finding in pelvis by u/s

研究者

相似试验